Establishment of a C3Hf Mammary Tumor Cell Line Expressing Endogenous Mouse Mammary Tumor Virus: Antigenic and Genetic Relationships of This Virus with Highly Oncogenic Mouse Mammary Tumor Viruses

A single-cell clone of C3Hf mammary tumor cells (clone 14) was developed into a continuous cell line expressing high levels of endogenous mouse mammary tumor virus (MMTV) with less than 0.1% murine leukemia virus expression. Comparison of the C3Hf MMTV protein profile on sodium dodecyl sulfatepolyacrylamide gel electrophoresis with that of C3H MMTV revealed that the protein content of the two viruses was quite similar. However, oligonucleotide fingerprints obtained of MMTV 70S RNA revealed that approximately 20% of the large oligonucleotides examined were unique to each virus. The oligonucleotide fingerprint indicated that although the viruses were similar, they differed in their genetic content. The differences in the two viruses extended to immunological differences in the major envelope glycoprotein, gp52. C3Hf MMTV competed only partially in a homologous radioimmunoassay for gp52 of C3H MMTV, whereas C3H MMTV gave complete competition, indicating that gp52 of C3H MMTV contained type-specific determinants not present on gp52 of C3Hf MMTV. Comparison of C3Hf MMTV with highly oncogenic C3H, GR, and RIII MMTVs in a homologous C3H MMTV gp52 assay gave two patterns of reactivity: complete competition by GR and C3H MMTV and incomplete competition by C3Hf and RIII MMTV. Absorption of anti-C3H MMTV serum by either C3Hf MMTV or RIII MMTV removed all antibodies against both viruses but not against GR and C3H MMTVs. These results indicate that C3H and GR MMTVs are more closely related to each other than to RIII and C3Hf MMTVs.

[1]  L. Arthur,et al.  Mice with Spontaneous Mammary Tumors Develop Type-Specific Neutralizing and Cytotoxic Antibodies Against the Mouse Mammary Tumor Virus Envelope Protein gp52 , 1979, Journal of virology.

[2]  L. Arthur,et al.  Immunological characterization of mouse mammary tumor virus p10 and its presence in mammary tumors and sera of tumor-bearing mice , 1979, Journal of virology.

[3]  H. Varmus,et al.  Integration of the DNA of mouse mammary tumor virus in virus-infected normal and neoplastic tissue of the mouse , 1979, Cell.

[4]  J. Racevskis,et al.  Phosphoproteins of the murine mammary tumor virus. , 1978, Virology.

[5]  J. Stephenson,et al.  Acquisition of oncogenicity by endogenous mouse type C viruses: effects of variations in env and gag genes , 1978, Journal of virology.

[6]  P. Bentvelzen,et al.  Genetic control of endogenous murine mammary tumour viruses reinvestigated. , 1978, European journal of cancer.

[7]  L. Arthur,et al.  Coexistence of the mouse mammary tumor virus (MMTV) major glycoprotein and natural antibodies to MMTV in sera of mammary tumor-bearing mice. , 1978, Virology.

[8]  L. Arthur,et al.  Oncogenicity of murine mammary tumor virus produced in tissue culture: brief communication. , 1978, Journal of the National Cancer Institute.

[9]  J. Schlom,et al.  Type-specific antigenic determinants on the major external glycoprotein of high- and low-oncogenic murine mammary tumor viruses , 1977, Journal of virology.

[10]  R. Lerner,et al.  Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[11]  R. Kettmann,et al.  Differences in mouse mammary tumor viruses: Relationship to early and late occurring mammary tumors , 1977, Cancer.

[12]  J. Schlom,et al.  A biochemical approach to the study of the transmission of mouse mammary tumor viruses in mouse strains RIII and C3H , 1976, International journal of cancer.

[13]  L. Arthur,et al.  In vitro system for production of mouse mammary tumor virus. , 1974, Applied microbiology.

[14]  A. Hackett,et al.  Tissue culture studies of mouse mammary tumor cells and associated viruses. , 1972, Journal of the National Cancer Institute.

[15]  W. Fiers,et al.  Preparative two-dimensional polyacrylamide gel electrophoresis of 32 P-labeled RNA. , 1972, Analytical biochemistry.

[16]  P. Blair Strain specificity in mouse mammary tumor virus virion antigens. , 1971, Cancer research.

[17]  P. Blair Immunology of the mouse mammary tumor virus: comparison of the antigenicity of mammary tumor virus obtained from several strains of mice. , 1970, Cancer research.

[18]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[19]  T. Dunn,et al.  Factors in the development of spontaneous mammary gland tumors in agent--free strain C3Hb mice. , 1950, Journal of the National Cancer Institute.

[20]  M. Shimkin,et al.  Technique Suitable for Quantitative Studies on the Mammary Tumor Inciter of Mice , 1942 .